A Study of Sapanisertib in Relapsed/Refractory NFE2L2-Mutated and Wild-Type Squamous Non-Small Cell Lung Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Paul Paik
Memorial Sloan Kettering Cancer Center
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
14 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Uc Davis Comprehensive Cancer Center
Davis, California, United States
- Providence Medical Group Santa Rosa - Cancer Center
Santa Rosa, California, United States
- Florida Cancer Specialists
Fort Myers, Florida, United States
- Ocala Oncology Center
Ocala, Florida, United States
- Florida Cancer Specialists
Tallahassee, Florida, United States
- Norton Cancer Institute, Downtown
Louisville, Kentucky, United States
- Karmanos Cancer Institute
Detroit, Michigan, United States
- Washington University - Patient Care Coordinator Center
St Louis, Missouri, United States
- Memorial Sloan Kettering Cancer Center - Thoracic
New York, New York, United States
- Zangmeister Cancer Center
Columbus, Ohio, United States
- Providence Cancer Institute Franz Clinic
Portland, Oregon, United States
- Upmc Cancer Pavilion
Pittsburgh, Pennsylvania, United States
- Tennessee Oncology
Nashville, Tennessee, United States
- Virginia Cancer Specialist, Pc
Fairfax, Virginia, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 21 Jul 2022
- Primary completion
- 24 Jan 2023
- Completion
- 24 Jan 2023
- Last update posted
- 24 Apr 2025
- Registered enrollment
- 7
- Registry id
- NCT05275673
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.